PDCD1 and central nervous system cancer: The presence of immunosuppressive signals, such as activation of the programmed cell death-1 (PD-1) pathway and the release of cytokines with immune-inhibitory properties by glioma and immune cells, contributes to the malignant phenotype and poor prognosis of these tumors [4, 5].